SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-058061
Filing Date
2023-07-19
Accepted
2023-07-19 09:21:40
Documents
14
Period of Report
2023-07-19
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea182000-8k_avalon.htm   iXBRL 8-K 40952
2 PRESS RELEASE ISSUED BY AVALON GLOBOCARE CORP., DATED JULY 19, 2023 ea182000ex99-1_avalon.htm EX-99.1 10527
3 GRAPHIC ex99-1_001.jpg GRAPHIC 9777
  Complete submission text file 0001213900-23-058061.txt   244128

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE albt-20230719.xsd EX-101.SCH 2983
5 XBRL LABEL FILE albt-20230719_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE albt-20230719_pre.xml EX-101.PRE 22375
8 EXTRACTED XBRL INSTANCE DOCUMENT ea182000-8k_avalon_htm.xml XML 3604
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

IRS No.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38728 | Film No.: 231095808
SIC: 2836 Biological Products, (No Diagnostic Substances)